- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06163716
GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia. (GOIZ_ZAINDU)
GOIZ ZAINDU Trial: a FINGER-like Multidomain Lifestyle Intervention Feasibility Study to Prevent Dementia in Southern Europe.
Study Overview
Status
Intervention / Treatment
Detailed Description
The GOIZ ZAINDU pilot trial is a one-year controlled, randomized, multidomain intervention trial, for prevention of cognitive decline, carried out in the municipality of Beasain in the Basque Country (Spain). Participants were recruited in collaboration with the primary care center health providers from Beasain Municipality after an informative prevention campaign on lifestyle and dementia.
After the baseline evaluation, all participants received in person verbal information on the potential benefits of caring for vascular risk factors, adhering to Mediterranean diet, and having good cognitive and physical activity routines. Participants were later randomly assigned to a standard health advice control group (RHA, control) or the multidomain intervention group (MD-Int). Random assignment followed a proportion of 1:1 and was stratified by age (<75 years vs.≥75 years), sex, and cognitive status (normal cognition vs. MCI).
- Regular health advice control (RHA) group. Participants randomized to the control group followed preventive programs already ongoing at their Primary Care Unit regarding physical activity, socialization, and smoking and alcohol usage. Visits to the GP and nurse depended on personal demands and necessities; nevertheless, annual consultation was recommended for all patients over 60 years old.
- Multidomain intervention (MD-Int) group. The MD-Int program was designed to provide tools and routines that participants could incorporate into daily living activities and reinforce the social environment. Although the program included standardized guidelines and exercises, each participant was considered individually, adapting nutritional requirements and physical and cognitive activity according to individual needs and abilities. This methodology is based on the FINGER trial design[23] but has been adapted to local resources and the healthcare system. GPs and nurses were involved in the follow-up visits. Most intervention activities were carried out at the local Primary Care Centre. Local town hall resources such as group activities for older adults at the municipality sports centre and current outdoor sports activities were incorporated in the study. The MD-Int program included: 1) individual follow-up visits every three months for cardiovascular risk factor monitoring and nutritional counselling with primary health care providers; 2) two nutritional workshops led by a nutritionist; 3) 20 hours of cognitive stimulation delivered through group sessions and 4) 40 hours of individual cognitive training exercises. Participants in the MD-Int group received recommendations to practice 2 to 6 hours of physical exercise per week and get involved in sports activities. Social stimulation was promoted through group activities.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gipuzkoa
-
Donostia-San Sebastián, Gipuzkoa, Spain, 20009
- CITA-alzheimer
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants were at least 60 years of age,
- had a CAIDE score ≥ 6 points and
- performed below than expected in at least one of two brief cognitive tests - Memory alteration test (T@M) and Fototest
- or scored two or higher in the AD8 informant's questionnaire of cognitive symptoms.
Exclusion Criteria:
- Exclusion criteria included the presence of poorly controlled cardiovascular or respiratory disease,
- previous diagnosis of dementia, ongoing neurological disorders, unstable psychiatric disease, evidence of any other severe disease of any etiology,
- or any situation, in the investigator's opinion, that could compromise safe engagement in the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Regular health advice control (RHA) group.
Participants randomized to the control group followed preventive programs already ongoing at their Primary Care Unit regarding physical activity, socialization, and smoking and alcohol usage.
Visits to the GP and nurse depended on personal demands and necessities; nevertheless, annual consultation was recommended for all patients over 60 years old.
|
|
Experimental: Multidomain intervention (MD-Int) group
The MD-Int program was designed to provide tools and routines that participants could incorporate into daily living activities and reinforce the social environment.
Although the program included standardized guidelines and exercises, each participant was considered individually, adapting nutritional requirements and physical and cognitive activity according to individual needs and abilities.
This methodology is based on the FINGER trial design but has been adapted to local resources and the healthcare system.
GPs and nurses were involved in the follow-up visits.
Most intervention activities were carried out at the local Primary Care Centre.
Local town hall resources such as group activities for older adults at the municipality sports centre and current outdoor sports activities were incorporated in the study.
|
The MD-Int program included: 1) individual follow-up visits every three months for cardiovascular risk factor monitoring and nutritional counselling with primary health care providers; 2) two nutritional workshops led by a nutritionist; 3) 20 hours of cognitive stimulation delivered through group sessions and 4) 40 hours of individual cognitive training exercises.
Participants in the MD-Int group received recommendations to practice 2 to 6 hours of physical exercise per week and get involved in sports activities.
Social stimulation was promoted through group activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retention rate
Time Frame: up to 1 year
|
Retention rate was defined as the proportion of participants who completed the 12-month trial period.
We considered a successful rate if less than 20% of participants dropped out.
|
up to 1 year
|
Adherence to each intervention component
Time Frame: up to 1 year
|
Study coordinators assessed the adherence to intervention activities by recording the number of workshops and follow-up visits attended and by checking the cognitive training workbook.
Self-reported information on weekly physical activity and attendance to group activities at the sports center was recorded for physical exercise.
|
up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global Cognitive performance
Time Frame: up to 1 year
|
Cognitive performance was assessed at baseline and 12 months with the modified Neuropsychological Test Battery (NTBm) which includes the following test: Wechler Memory Scale-III Logical Memory, Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word List, WMS-R Visual Paired Associates, Category Fluency, Wechler Adult Inteligence Scale-III Digit Span, Concept Shifting Test, Trail Making Test, a shortened 40-stimuli version of Stroop Test, and Letter Digit Substitution Test.
|
up to 1 year
|
Performance in each cognitive domain
Time Frame: up to 1 year
|
NTBm Cognitive global, executive function, memory, processing speed scores will be obtained.
Composite cognitive z-scores based on the results from all single tests will be calculated.
Single z-scores will be calculated using baseline mean and standard deviations of the study sample and, for each composite score, single z-scores will be averaged.
Higher scores suggest better performance.
|
up to 1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mikel Tainta, MD, Study Principal Investigator
- Study Chair: Pablo Martinez-Lage, MD, PhD, Scientific Director
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GZ trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Consent for publication. All participants signed the corresponding informed consent which included an explicit consent for publication the study results and experience.
Availability of data and materials. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Decline
-
Jean-François DémonetUniversity of Lausanne HospitalsActive, not recruitingCognitive Performance | Functional Capacity | Subjective Cognitive Decline | Age-related Cognitive DeclineSwitzerland
-
Rotman Research Institute at BaycrestSunnybrook Health Sciences Centre; University of Waterloo; Toronto Rehabilitation... and other collaboratorsTerminatedSubjective Cognitive Decline | Age-Related Cognitive DeclineCanada
-
National Taiwan University HospitalNational Taiwan Science Education Center(NTSEC)RecruitingCognitive Training | Subjective Cognitive DeclineTaiwan
-
Sahmyook UniversityCompletedCognition Disorders in Old Age | Subjective Memory Decline | Cognitive Decline, MildKorea, Republic of
-
University of Milano BicoccaRecruitingMild Cognitive Impairment | Subjective Cognitive DeclineItaly
-
Beijing Hospital of Traditional Chinese MedicineUnknownSubjective Cognitive Decline | Subjective Cognitive ComplaintChina
-
BaycrestCompletedSubjective Cognitive DeclineCanada
-
Evidation HealthNeurotrackCompleted
-
Fundacion Clinic per a la Recerca BiomédicaUnknownSubjective Cognitive Decline
-
Vanderbilt University Medical CenterRecruiting
Clinical Trials on Multidomain intervention (MD-Int) group
-
Inha University HospitalRecruitingMild Cognitive ImpairmentKorea, Republic of
-
Institut National de la Santé Et de la Recherche...National Research Agency, FranceCompletedPhysical Disability | Physical Frailty | Mobility DisabilityFrance
-
Chang Gung Memorial HospitalRecruitingCognitive DeclineTaiwan
-
Huashan HospitalSchool of Public Health,Fudan University; Medicine-Mental Health Center of... and other collaboratorsActive, not recruitingMild Cognitive Impairment | The Cognitive Normal ElderlyChina
-
Donders Centre for Cognitive NeuroimagingWageningen University and ResearchActive, not recruitingAging | Cognitive Decline | Risk Reduction | Life StyleNetherlands
-
Alzheimercentrum AmsterdamRadboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsActive, not recruitingCognitive Decline | Risk Reduction | Life StyleNetherlands
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingStroke | Cognitive Impairment | DementiaChina
-
Inha University HospitalKorea Health Industry Development InstituteCompletedMild Cognitive Impairment | AgedKorea, Republic of
-
Weill Medical College of Cornell UniversityRecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Neuroglee TherapeuticsCompletedEffectiveness and Safety of a Digitally Based Multidomain Intervention for Mild Cognitive ImpairmentMild Cognitive ImpairmentSingapore